TICKERNERD
Menu
NUTXNUTXHealthcare · Medical Care Facilities

NUTX Stock Forecast: Nutex Health, Inc. Price Predictions for 2026-2027

Last close, 14 Oct 2026
$197
−3.65% on the day

The 5 Wall Street analysts covering Nutex Health, Inc. hold a median 12-month price target of $306 — +55.4% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 88 of 100 as at 14 Oct 2026 — inside the top quartile. Here, the model and the Street point the same way.

Market cap
$1.4B
Ticker Nerd rank
88 / 100
Median analyst target
$306
Analysts covering
5
Revenue$210.8M−13.6% y/y
Operating income$121.7M
Net income$96.3M
Free cash flow$31.7M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−7.6%
1M
−9.3%
YTD
+19.6%
1Y
+98.0%
From 52W high
−12.5%
From 52W low
+126.3%
$87
$225
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

NUTX stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Nutex Health, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 14 Oct 2026
88 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Quality
99
Value
95
Momentum
91
Revisions
82
Growth
66
Accruals
52
Size
39
Issuance
33
Volatility
13

Quality (99): The business earns solid, repeatable profits on what it owns.

Volatility (13): The share price moves around a lot.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

NUTX stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on NUTX, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$100$150$200$250$300Jan 26Apr 26Jul 26Oct 26NUTXHigh $325Median $306Low $200

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says5 analysts
5 Buy0 Hold0 Sell
Low $200Median $306High $325

The green dot is the last close — the median target sits +55.4% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 3 moved their price target up and 0 moved it down.

DateFirmActionRatingTarget
25 Sept 2026Freedom Capital MarketsMaintainsBuy$280 → $306
4 Sept 2026B. Riley SecuritiesMaintainsBuy$290 → $325
4 Sept 2026B. Riley SecuritiesMaintainsBuy—
11 Aug 2026Lake StreetMaintainsBuy$235 → $310
11 Aug 2026Lake StreetMaintainsBuy—
26 June 2026B. Riley SecuritiesInitiatesBuy$290
26 June 2026B. Riley SecuritiesInitiatesBuy—
2 June 2026Lake StreetInitiatesBuy—
26 Aug 2025Maxim GroupMaintainsBuy—
10 July 2025BenchmarkReiteratesBuy—
20 May 2025Maxim GroupMaintainsBuy—
15 May 2025BenchmarkMaintainsBuy—
9 Apr 2025BenchmarkMaintainsBuy—
8 Apr 2025Maxim GroupMaintainsBuy—
13 Feb 2025Maxim GroupMaintainsBuy—
12 Nov 2024BenchmarkMaintainsBuy—
12 Nov 2024Maxim GroupMaintainsBuy—
18 Sept 2024Maxim GroupInitiatesBuy—
21 Aug 2024BenchmarkMaintainsBuy—
25 Jan 2024BenchmarkMaintainsBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. NUTX appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

NUTX vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 14 Oct 2026, Nutex Health, Inc. returned +98.0% against +17.5% for the S&P 500, dividends included.

NUTX vs S&P 500, last 12 monthsTotal return, rebased to 100
100150200Jan 26Apr 26Jul 26Oct 26NUTXS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

NUTX analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+29.2%
Analysts raising
5
Analysts cutting
0
Fundamentals

Nutex Health, Inc. (NUTX) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
7.8×

Cheaper than 62% of US stocks

Price / sales
1.6×

Cheaper than 57% of US stocks

Price / book
3.4×

Cheaper than 28% of US stocks

EV / EBITDA
3.3×

Cheaper than 56% of US stocks

Growth & margins
Revenue growth (YoY)
−13.6%

Higher than 13% of US stocks

Earnings growth (YoY)
−13.6%

Higher than 24% of US stocks

Gross margin
67.0%

Higher than 80% of US stocks

Operating margin
57.8%

Higher than 98% of US stocks

Net margin
21.2%

Higher than 83% of US stocks

Returns & dividend
Return on equity
64.6%

Higher than 94% of US stocks

Return on assets
33.3%

Higher than 99% of US stocks

Dividend yield
0.0%

Higher than 1% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Nutex Health, Inc. (NUTX) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Nutex Health, Inc. has a market value of $1.4B and an enterprise value of $1.7B.

  • Revenue in the twelve months to 30 June 2026: $846.7M. The latest quarter shrank 13.6% year on year.

  • Net income over the same four quarters: $272.5M, a 32.2% net margin.

  • Free cash flow in the twelve months to 30 June 2026: $274.2M.

  • Nutex Health, Inc. spent $84.1M on dividends in the twelve months to 30 June 2026.

  • Shares outstanding: 6.8M.

  • Trailing P/E: 7.8×; forward P/E: 9.6× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 0.00%, paying out 0% of earnings.

  • Nutex Health, Inc. employs 1,037 people — $817K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 14 Oct 2026

Data provided by Twelve Data

Peers

NUTX vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Care Facilities
CompanyMarket capTKN rank
NUTXNutex Health, Inc.$1.4B
88
PNTGThe Pennant Group, Inc.$1.4B
72
AGLAgilon Health, Inc.$1.5B
70
AMNAMN Healthcare Services, Inc.$1.5B
100
HCSGHealthcare Services Group, Inc.$1.5B
95
USPHU.S. Physical Therapy, Inc.$1.3B
57
INNVInnovAge Holding Corp.$1.2B
98

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Nutex Health, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest NUTX news & analysis

Top Healthcare Stocks: Playing Offense And Defense For The Win

Seeking Alpha · 12 Oct 2026neutral

A Seeking Alpha article says healthcare may offer both growth potential and defensive characteristics amid macroeconomic uncertainty, citing aging demographics, rising medical demand, and spending growth. It highlights select healthcare services and facilities companies with strong forward revenue, EBITDA, and earnings growth.

Why it matters — The article discusses broad trends relevant to healthcare services and facilities, but the excerpt does not specifically address Nutex Health.

5 Stocks With Recent Price Strength After a Mixed September

Zacks Investment Research · 5 Oct 2026positive

Zacks Investment Research highlighted Nutex Health (NUTX) among five stocks showing recent price strength and strong momentum after a mixed September, with improving earnings estimates noted.

Why it matters — A NUTX watcher would care because the stock is being called out for recent price strength and improving earnings estimates, signaling positive momentum for the company.

Bet on These 4 Stocks With Strong Net Profit Margins to Boost Returns

Zacks Investment Research · 1 Oct 2026positive

Zacks Investment Research highlighted Nutex Health, Inc. (NUTX) among four stocks with strong net profit margins, positioning it as a candidate for a robust portfolio.

Why it matters — NUTX watchers would care because the company is being recognized for its strong net profit margins, a key indicator of profitability.

Nutex Health: A High-Risk, High-Reward Play For Speculative Investors

Seeking Alpha · 26 Sept 2026positive

Nutex Health has surged 134% since April, driven by its out-of-network micro-hospital model and expanding margins. After years of struggle, the company staged a turnaround in 2026 with strong EPS growth, leveraging the No Surprises Act's arbitration process to sustain margins against insurer underpayment.

Why it matters — NUTX watchers would care because the article highlights that the company's turnaround and recent share surge rest on its arbitration-based dispute resolution strategy, which is central to sustaining margins.

Nutex Health: The Stock Has Had A Great Run, But New Guidance Justifies A Higher Target Price (Rating Upgrade)

Seeking Alpha · 24 Sept 2026positive

Seeking Alpha rates Nutex Health a Strong Buy and raises its target price to $290.43, citing upside of 39.1%. The firm notes that NUTX's profitability and growth metrics outpace peers, supported by the No Surprises Act and cost controls, with consensus EPS estimates for FY2026 and FY2027 raised.

Why it matters — NUTX watchers would note the upgraded target price and raised earnings estimates, which reflect new guidance and stronger expected profitability relative to peers.

FAQ

Frequently asked questions about NUTX stock

What is the NUTX stock price forecast for 2026-2027?

The 5 Wall Street analysts covering Nutex Health, Inc. have a median 12-month price target of $306, with estimates ranging from $200 to $325. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is NUTX stock a buy right now?

Of the 5 analysts covering Nutex Health, Inc., 5 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Nutex Health, Inc. 88 out of 100 across roughly 4,600 US stocks as at 14 Oct 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank NUTX?

As at 14 Oct 2026, Nutex Health, Inc. ranks 88 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Quality (99 of 100).

Will NUTX stock go up?

No one can know that. What the data says: the median 12-month target from 5 analysts implies +55.4% from the last close, and Ticker Nerd's factor model ranks Nutex Health, Inc. 88 out of 100 as at 14 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the NUTX stock forecast for 2030?

No analyst covering Nutex Health, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for NUTX are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $200 to $325 over the next 12 months.

How has NUTX stock performed over the past year?

Nutex Health, Inc. returned +98.0% over the 12 months to 14 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Nutex Health, Inc. do?

Nutex Health Inc. is a healthcare management and operations company that provides care delivery and support services through its Hospital Division and Population Health Management Division.

What is the latest news on NUTX?

The most recent item we track (Seeking Alpha, 12 Oct 2026): "Top Healthcare Stocks: Playing Offense And Defense For The Win". A Seeking Alpha article says healthcare may offer both growth potential and defensive characteristics amid macroeconomic uncertainty, citing aging demographics, rising medical demand, and spending growth. It highlights select healthcare services and facilities companies with strong forward revenue, EBITDA, and earnings growth.

Company

About Nutex Health, Inc.

Nutex Health Inc. is a healthcare management and operations company that provides care delivery and support services through its Hospital Division and Population Health Management Division. Nutex Health operates a network of micro hospitals, specialty hospitals, and hospital outpatient departments that offer emergency care, inpatient services, behavioral health, imaging, laboratory testing, and pharmacy services. Its population health business builds and manages provider networks, including independent physician associations, and provides administrative and technology support through a cloud-based platform. The company also includes a real estate segment that owns and leases hospital properties. Nutex Health serves patients and physician groups across multiple U.S. states, with a model centered on integrated local healthcare access and coordinated care operations.

CEO Dr. Thomas T. Vo M.B.A., M.D. · 1,037 employees · United States · https://www.nutexhealth.com